SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Infinity Pharmaceuticals
INFI 0.0160-4.8%Sep 29 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (167)4/15/2008 6:57:14 PM
From: Mike McFarland  Read Replies (1) of 210
 
Infinity's Hedgehog Antagonist Delays Tumor Growth Following
Chemotherapy in Preclinical Model of Small Cell Lung Cancer;
Data Presented At AACR

IPI-926 Also Shows Promise as Potential Treatment for Acute
Lymphocytic Leukemia; Additional Data Show Use of Skin as
Potential Indicator of Biological Activity of IPI-926

investor.ipi.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News